EX-2.5 2 dex25.htm SECURED CREDITOR ASSET PURCHASE AGREEMENT SECURED CREDITOR ASSET PURCHASE AGREEMENTSecured Creditor Asset Purchase Agreement • May 5th, 2020 • Colorado
Contract Type FiledMay 5th, 2020 JurisdictionThis SECURED CREDITOR ASSET PURCHASE AGREEMENT (the “Agreement”) is entered into as of February 23, 2010, by and between SILICON VALLEY BANK, a California State Chartered Bank, as agent for itself and for Gold Hill Venture Lending 03, LP (collectively, “Seller”), and SILICON GRAPHICS INTERNATIONAL CORP., a Delaware corporation (“Purchaser”), with the consent and acknowledgement of ERIC N. GROTHE, as the Receiver (defined below) of Copan Systems, Inc. a Delaware corporation (the “Borrower”) .
SECURED CREDITOR ASSET PURCHASE AGREEMENT PRIVATE UCC SALESecured Creditor Asset Purchase Agreement • May 5th, 2020 • Colorado
Contract Type FiledMay 5th, 2020 JurisdictionThis SECURED CREDITOR ASSET PURCHASE AGREEMENT PRIVATE UCC SALE (the “Agreement”) is hereby entered into on July 2, 2013 (the “Effective Date”), by and between SILICON VALLEY BANK, a California state-chartered bank (“Seller”), pursuant to C.R.S. § 9-617 for itself and for and on behalf of SOUTHWEST WINDPOWER, INC., a Delaware corporation (“Borrower”), with an address of 3003 Tasman Drive, Santa Clara, California 95054, and XZERES CORP, a Nevada corporation (the “Purchaser”), with principal offices located at 9025 SW Hillman Ct., Suite 3126, Wilsonville, Oregon 97070.
SECURED CREDITOR asset PURCHASE AGREEMENT by and among INTERPACE BIOPHARMA, INC. as the Buyer, partners for growth iv, l.p. as the Seller and CANCER GENETICS, INC. And INTERPACE DIAGNOSTICS GROUP, INC. (solely for purposes of the Specified Sections)...Secured Creditor Asset Purchase Agreement • July 19th, 2019 • Cancer Genetics, Inc • Services-medical laboratories
Contract Type FiledJuly 19th, 2019 Company IndustryThis Secured Creditor Asset Purchase Agreement (this “Agreement”) is made as of July 15, 2019, by and among Interpace BioPharma, Inc., a Delaware corporation (the “Buyer”), Partners for Growth IV, L.P., a Delaware limited partnership (the “Seller”), Cancer Genetics, Inc., a Delaware corporation (including any and all BP Subsidiaries, “CGI”) and, solely for purposes of the Specified Sections, Interpace Diagnostics Group, Inc., a Delaware corporation (“IDXG”). Each of the Buyer, the Seller and CGI is a “Party” and collectively, the “Parties”.